K. Neriishi et al., PREVALENCE OF HEPATITIS-B SURFACE-ANTIGEN, HEPATITIS-B E-ANTIGEN AND ANTIBODY, AND ANTIGEN-SUBTYPES IN ATOMIC-BOMB SURVIVORS, Radiation research, 144(2), 1995, pp. 215-221
On the basis of previous studies showing an association between hepati
tis B surface antigen (HBsAg) positivity and radiation exposure in ato
mic bomb (A-bomb) survivors, we investigated further the active state
of hepatitis B virus (HBV) infection by incorporating tests for hepati
tis B e antigen (HBeAg) and hepatitis B e antibody (anti-HBe) and HBsA
g subtypes into our biennial health examinations. Among 6548 A-bomb su
rvivors for whom HBsAg was assayed between July 1979 and July 1981, 12
9 persons were HBsAg positive. HBeAg and anti-HBe were measured in 104
of these persons and subtypes of HBsAg in 98 persons. Among those exp
osed to radiation (average liver dose 0.58 Sv), the odds ratio of HBsA
g positivity tended to increase with radiation dose (P for trend = 0.0
24). The P values for association between the prevalence of HE e antig
en and radiation dose and between the prevalence of anti-HBe and radia
tion dose were 0.094 and 0.17, respectively. The HE antigen subtype ad
r was predominant over other subtypes in both Hiroshima and Nagasaki,
but the distribution of subtypes did not seem to differ in relation to
radiation dose. These results suggested that A-bomb survivors remain
in an active state of HBV infection and that the mechanism(s) of seroc
onversion may be impaired. (C) 1995 by Radiation Research Society